| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2005 | CA2549955A1 Heterocyclic derivatives as gpcr receptor agonists |
| 07/07/2005 | CA2549935A1 Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen |
| 07/07/2005 | CA2549720A1 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549510A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 07/07/2005 | CA2549485A1 Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection |
| 07/07/2005 | CA2549429A1 Fat composition |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549308A1 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
| 07/07/2005 | CA2549183A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
| 07/07/2005 | CA2549173A1 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/07/2005 | CA2549118A1 Core 2 glcnac-t inhibitors |
| 07/07/2005 | CA2549116A1 Combination therapies employing a composition comprising a hmg coa reductase inhibitor and a vitamin b6 related compound |
| 07/07/2005 | CA2549114A1 Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |
| 07/07/2005 | CA2549103A1 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 07/07/2005 | CA2549008A1 Selective peroxisome proliferator activated receptor modulators |
| 07/07/2005 | CA2549007A1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 07/07/2005 | CA2548917A1 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 07/07/2005 | CA2548824A1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 07/07/2005 | CA2548662A1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/07/2005 | CA2548410A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 07/07/2005 | CA2548408A1 Cefdinir oral suspension |
| 07/07/2005 | CA2548374A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | CA2548304A1 Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition |
| 07/07/2005 | CA2548108A1 Use of superoxide dismutase mimetics and reductase glutathione in the form of anticancer drugs |
| 07/07/2005 | CA2547746A1 Mitotic kinesin inhibitors |
| 07/07/2005 | CA2547617A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/07/2005 | CA2547209A1 Mitotic kinesin inhibitors |
| 07/07/2005 | CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
| 07/07/2005 | CA2546943A1 Novel compounds |
| 07/07/2005 | CA2546565A1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and an agent intervening in the prostaglandin metabolism |
| 07/07/2005 | CA2546472A1 Nutritional composition for wound healing |
| 07/07/2005 | CA2545962A1 Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
| 07/07/2005 | CA2545947A1 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 07/07/2005 | CA2545777A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/07/2005 | CA2545762A1 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
| 07/07/2005 | CA2545522A1 9-desoxoerythromycin compounds as prokinetic agents |
| 07/07/2005 | CA2545085A1 Use of piketprofen for the preparation of a pharmaceutical composition to treat rosacea |
| 07/07/2005 | CA2545080A1 Use of idrocilamide for the preparation of a pharmaceutical composition of rosacea |
| 07/07/2005 | CA2545074A1 Use of fepradinol for the production of a pharmaceutical composition for the treatment of rosacea |
| 07/07/2005 | CA2543578A1 Genes commonly regulated by different classes of antidepressants |
| 07/07/2005 | CA2540230A1 Aminopyridine-derivatives as inductible no-synthase inhibitors |
| 07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550705A1 Allergen inactivator |
| 07/06/2005 | EP1550675A1 Phospholipid derivative |
| 07/06/2005 | EP1550674A1 Chitosan-containing polysaccharide, process for producing the same and use thereof |
| 07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 07/06/2005 | EP1550667A1 Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same |
| 07/06/2005 | EP1550663A1 New crystalline forms of antiarrhythmic compounds |
| 07/06/2005 | EP1550662A1 Novel adenine compound and use thereof |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1550471A1 Intraocular implants for preventing transplant rejection in the eye |
| 07/06/2005 | EP1550463A1 Preparation for facilitating site-specific gene conversion and preparation for gene therapy |
| 07/06/2005 | EP1550462A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1550459A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1550452A1 Composition comprising an aqueous extract of red vine leaves and a antthrombotic agent for the treatment of chronic venous insufficiencies |
| 07/06/2005 | EP1550451A1 Composition comprising an aqueous extract of red vine leaves and a diuretic for the treatment of chronic venous insufficiencies |
| 07/06/2005 | EP1550450A1 Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies |
| 07/06/2005 | EP1550448A1 Histamine release inhibitor |
| 07/06/2005 | EP1550447A1 Menstrual cycle control and improvement of conception rates in females |
| 07/06/2005 | EP1550446A1 Use of 1-(5-isoquinolinesulfonyl) homopiperazine for treating and preventing hypopigmentary disorders |
| 07/06/2005 | EP1550445A1 Method for the treatment of female specific pain using metanicotine derivatives |
| 07/06/2005 | EP1550444A1 Controlled releases system containing temozolomide |
| 07/06/2005 | EP1550443A1 Composition against stress-related diseases |
| 07/06/2005 | EP1550442A1 Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction |
| 07/06/2005 | EP1550441A1 Compositions for a synergic topical therapy of neuromuscular pain |
| 07/06/2005 | EP1550438A2 Method for preparing a medicated candy containing ambroxol and the thus obtained candy |
| 07/06/2005 | EP1550433A1 Use of ecdysteroids for teh preparation of cosmetic or dermatologic compositions for avoiding the hair loss |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells |
| 07/06/2005 | EP1549740A2 Oligodendrocyte production from multipotent neural stem cells |
| 07/06/2005 | EP1549713A1 Synergistic uv absorber combination |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549658A1 Glucose-based compounds with affinity to p-selectin |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549652A1 Fused azole-pyrimidine derivatives |
| 07/06/2005 | EP1549651A1 Kinase inhibitors |
| 07/06/2005 | EP1549646A2 Piperidine derivatives |
| 07/06/2005 | EP1549644A1 Azolidinone-vinyl fused-benzene derivatives |
| 07/06/2005 | EP1549642A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 07/06/2005 | EP1549636A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549633A1 Nicotine-containing, controlled release composition and method |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549626A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549622A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
| 07/06/2005 | EP1549619A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 07/06/2005 | EP1549616A1 Organic acid salt of amlodipine |
| 07/06/2005 | EP1549615A1 Naphthamide derivatives and their use |
| 07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |